Patient Guide: Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 83 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT03647878
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase: Not Specified

Where You Can Participate

This study is available at 83 locations across the country.

Top locations include:
  • • Leoben,
  • • Linz,
  • • Linz,
  • • And 80 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment. - Join Clinical Trial NCTNCT03647878

How to Join This Clinical Trial - NCTNCT03647878

Learn how to participate in this Not Specified trial studying an investigational therapy for Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT03647878 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 83 locations. Find a study site near you:

Clinical Research Site

Leoben, A-8700 - Austria

Status: Contact for availability

Clinical Research Site

Linz, 4020 - Austria

Status: Contact for availability

Clinical Research Site

Linz, 4021 - Austria

Status: Contact for availability

Clinical Research Site

Salzburg, A-5020 - Austria

Status: Contact for availability

Clinical Research Site

Vöcklabruck, A-4840 - Austria

Status: Contact for availability

Clinical Research Site

Wels, 4600 - Austria

Status: Contact for availability

Clinical Research Site

Aachen, - Germany

Status: Contact for availability

Clinical Research Site

Aachen, - Germany

Status: Contact for availability

Clinical Research Site

Aschaffenburg, 63739 - Germany

Status: Contact for availability

Clinical Research Site

Augsburg, 86156 - Germany

Status: Contact for availability

And 73 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships